During the past decade, Hopital Prive Jean Mermoz; Cancerologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Prive Jean Mermoz; Cancerologie" are "Breast Cancer" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Hopital Prive Jean Mermoz; Cancerologie" in a lesser frequency.

Most popular intervention types in "Hopital Prive Jean Mermoz; Cancerologie" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Fulvestrant" (1 trials), "Inavolisib" (1 trials), "Investigator's choice of anti-cancer treatment (except immunotherapy)" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Prive Jean Mermoz; Cancerologie" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Prive Jean Mermoz; Cancerologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hopital Prive Jean Mermoz; Cancerologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Prive Jean Mermoz; Cancerologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".